Somatostatin receptor subtype expression and function in human vascular tissue

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Curtis, Susan B ^a   Hewitt, Jeff ^a   Yakubovitz, Svetlana ^a   Anzarut, Alexander ^a   Hsiang, York N ^a   Buchan, Alison M J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Actin stress fibers; Endothelial cells; Human umbilical vein endothelial cells; Lamellipodia

Indexed keywords

ACTIN; ANGIOPEPTIN; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LAMELLIPODIUM; PRIORITY JOURNAL; VASCULAR TISSUE;

EID: 0033933498     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h1815     Document Type: Article

References (35)

1. Barber DL, McGuire ME, and Ganz MB. Beta-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP. J Biol Chem 264: 21038-21042, 1989.
2. Chen JC, Hsiang YN, and Buchan AMJ. Somatostatin receptor expression in rat iliac arteries after balloon injury. J Invest Surg 10: 17-23, 1997.
3. Clowes AW and Reidy MA. Prevention of stenosis after vascular reconstruction. Pharmacologic control of intimai hyperplasia - a review. J Vasc Surg 13: 885-891, 1991.
4. Clowes AW. The role of aspirin in enhancing arterial graft patency. J Vasc Surg 3: 381, 1986.
5. Conte JV, Foegh ML, and Calcagno D. Peptide inhibition of myointimal proliferation following angioplasty in rabbits. Transplant Proc 21: 3686-3688, 1989.
6. Coy DH, Murphy WA, Raynor K, and Reisine T. The new pharmacology of somatostatin and its multiple receptors. J Pediatr Endocrinol 6: 205-209, 1993.
7. Coy DH and Taylor JE. Receptor-specific somatostatin analogs: correlations with biological activity. Metabolism 45: 21-23, 1996.
8. Dezsi L, Szentivanyi M Jr, Dornyei G, Lowenstein L, Farago M, Tulassay T, and Monos E. Regional differences in nitric oxide-dependent vascular responses to somatostatin. Physiol Res 45: 291-296, 1996.
9. Emanuelsson H, Beatt KJ, Bagger J-P, Balcon R, Heikkila J, Piessens J, Schaeffer M, Suryapranata H, and Foegh M. Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographie restenosis. European Angiopeptin Study Group. Circulation 91: 1689-1696, 1995.
10. Eriksen UH,Amtorp O, Bagger J-P, Emanuelsson H, Foegh M, Henningsen P, Saunamaki K, Schaeffer M, Thayssen P, and Orskov H. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J 130: 1-8, 1995.
11. Fluori T and Schettini G. Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors. J Mol Endocrinol 17: 89-100, 1996.
12. Foegh ML, Khirabadi BS, Chambers E, Amamoo S, and Ramwell PW. Inhibition of coronary artery transplant atherosclerosis in rabbits by angiopeptin, an octapeptide. Atherosclerosis 78: 229-236, 1989.
13. Gibbons GH and Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 330: 1431-1438, 1994.
14. Glagov S. Is intimal hyperplasia an adaptive response or a pathologic process? Observations on the nature of nonatherosclerotic intimai thickening. J Vasc Surg 10: 571-573, 1989.
15. Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, and Pepine CJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation 89: 1511-1517, 1994.
16. Hong MK, Bhatti T, Mathews BJ, Stark KS, Cathapermal SS, Foegh ML, Ramwell PW, and Kent KM. The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit. Circulation 88: 638-648, 1993.
17. Hoyer D, Taylor E, O'Carroll A-M, Patel YC, Schonbrunn A, Reisine T, Bell GI, Kenakin T, Berelowitz M, Epelbaum J, Feniuk W, and Humphrey PP. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16: 86-88, 1995.
18. Kent KM, Williams DO, Cassagneau B, Broerick T, Chapekis A, Simpfendorfer C, Cote G, Bates M, Tauscher G, Kuntz R, Popma JJ, and Foegh M. Double blind controlled trial of the effect of angiopeptin on coronary restenosis following balloon angioplasty (Abstract). Circulation 88: 1506, 1993.
19. Leszczynski D, Joseph MD, Founier RS, and Foegh ML. Angiopeptin, the octapeptide analogue of somatostatin decrease rat heart endothelial cell adhesiveness for mononuclear cells. Regul Pept 43: 131-140, 1993.
20. Liapakis G, Hoeger C, Rivier J, and Reisine T. Development of a selective agonist at the somatostatin receptor subtype SSTR1. J Pharmacol Exp Ther 276: 1089-1094, 1996.
21. Light JT, Bellan JA, Chen IL, Longenecker LL, Murphy WA, Coy DH, Kadowitz PJ, and McNamara DB. Angiopeptin enhanced acetylcholine-enhanced relaxation and inhibits intimal hyperplasia after vascular injury. Am J Physiol Heart Circ Physiol 265: H1265-H1274, 1993.
22. Lindner V, Lappi DA, Baird A, Majack RA, and Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68: 106-113, 1991.
23. Lundergan C, Foegh ML, Vargas R, Eufemio M, Bormes GW, Kot PA, and Ramwell PW. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80: 49-55, 1989.
24. Luu TN, Chester AH, O'Neil GS, Tadjkarimi S, and Yacoub MH. Effects of vasoactive neuropeptides on human saphenous vein. Br Heart J 67: 474-477, 1992.
25. McBride W, Lange RA, and Hillis RD. Restenosis after successful coronary angioplasty. N Engl J Med 318: 1734, 1988.
26. Mooradian DL, Fernandes B, Diglio CA, and Lester BR. Angiopeptin inhibits vascular smooth muscle migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation. J Cardiovasc Pharmacol 25: 611-618, 1995.
27. Patel YC, Greenwood MT, Wrszynska A, Pannetta R, and Srikant CB. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 198: 605-612, 1994.
28. Patel YC and Srikant CB. Somatostatin Receptors. Trends Endocrinol Metab 8: 398-405, 1998.
29. Ross R. Mechanisms of smooth muscle proliferation - the role of cytokines and growth factors. J Vasc Surg 10: 563-564, 1989.
30. Serruys P, de Jaegere PPT, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, and Morel M. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331: 489-495, 1994.
31. Tominaga T and Barber DL. Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol Biol Cell 9: 2287-2303, 1998.
32. Tornebrandt K, Nobin A, and Owman C. Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides 8: 251-256, 1987.
33. Vargas R, Bormes BW, Wroblewska B, Foegh ML, Kot PA, and Ramwell PW. Angiopeptin inhibits thymidine incorporation in rat carotid artery in vitro. Transplant Proc 21: 3702-3703, 1989.
34. Vouret-Craviari V, Boquet P, Pouyssegur J, and Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of rho proteins in endothelial barrier function. Mol Biol Cell 9: 2639-2653, 1998.
35. Wojicak-Stothard B, Entwistle A, Garg R, and Ridley AJ. Regulation of TNF-induced reorganization of the actin cytoskeleton and cell-cell junctions by rho, rac, and cdc42 in human endothelial cells. J Cell Physiol 176: 150-165, 1998.